Day 1 - Thursday March 21
8:30 - 11:30 am
Session 1:
Basics and Biology of Cannabinoids and the Endocannabinoid System

Chair: Ruth Ross
Cannabis and its Constituents Jonathan Page, Ph.D.
The Pharmacokinetics of Cannabis in Humans Ryan Vandrey, Ph.D.
Introduction to the Endocannabinoid System Matthew Hill, Ph.D.
Everything you Need to Know about Cannabidiol Cecilia Hillard, Ph.D.
Sex Differences in the Effects of Cannabis Ziva Cooper, Ph.D.

1:30 - 4:30 pm
Session 2:
Recreational Cannabis Use and Misuse

Chair: Steve Laviolette
Translational Animal Models of Cannabis Use Ryan McLaughlin, Ph.D.
Challenges in Developing a Field Sobriety Test for Cannabis Harriet deWit, Ph.D.
Effects of Cannabis Products on Brain Structure, Cognition and Mood Kent Hutchison, Ph.D.
Cannabis Use Disorder: Current Perspectives Margaret Haney, Ph.D.
Cannabis Use in Adolescence: Potential Interventions Patricia Conrod, Ph.D.

Day 2 – Friday, March 22
8:30 - 11:30 am
Session 3:
Medical Cannabis and Therapeutic Targets

Chair: Lynda Balneaves
Process and Practicalities of Medical Cannabis in Canada Danial Schechter, M.D.
Expecting the Unexpected: Managing Drug Interactions with Cannabis (and Constituents) Maria Zhang, Pharm.D.
Cannabinoids and Neurological Conditions Colleen O’Connell, M.D.
Cannabidiol as a Treatment for Opiate Addiction? Yasmin Hurd, Ph.D.
The Therapeutic Potential of Cannabis for PTSD: An Update Marcel Bonn-Miller, Ph.D.

1:30 - 4:30 pm
Session 4:
Harm Reduction and Public Health Implications of Cannabis Legalization

Chair: Bernard LeFoll
Centering the Perspectives of Cannabis Users: Insights from Qualitative Research Rebecca Haines-Saah, Ph.D.
Race, Cannabis and the Canadian War on Drugs Akwasi Owusu-Bempah, Ph.D.
Assessing the Use of Cannabis to Address the National Opioid Crisis MJ Milloy, Ph.D.
Cannabis and Driving Bruna Brands, Ph.D.
Cannabis Advertising David Hammond, Ph.D.